Aptevo Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2024 | 516.79 K | $94.00 K | 193.66% | 4.11% |
| SABBY MANAGEMENT, LLC | 02/14/2024 | 349.47 K | $63.25 K | -73.81% | 2.78% |
| CITADEL ADVISORS LLC | 02/14/2024 | 262.12 K | $47.44 K | 100.00% | 2.08% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2024 | 159.00 K | $28.78 K | 11.34% | 1.26% |
| SQUAREPOINT OPS LLC | 02/14/2024 | 138.70 K | $25.10 K | 100.00% | 1.10% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2024 | 104.61 K | $18.93 K | 100.00% | 0.83% |
| VANGUARD GROUP INC | 03/11/2024 | 91.73 K | $16.60 K | -58.51% | 0.73% |
| ARMISTICE CAPITAL, LLC | 02/13/2024 | 61.13 K | $11.07 K | -95.05% | 0.49% |
| CANTOR FITZGERALD, L. P. | 02/14/2024 | 58.53 K | $10.59 K | 3.86% | 0.47% |
| BLACKROCK INC. | 02/13/2024 | 46.64 K | $8.44 K | -2.17% | 0.37% |
| ALYESKA INVESTMENT GROUP, L.P. | 02/14/2024 | 45.98 K | $8.32 K | 100.00% | 0.37% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/13/2024 | 43.20 K | $7.82 K | -42.67% | 0.34% |
| BAADER BANK AKTIENGESELLSCHAFT | 02/08/2024 | 15.09 K | $2.03 K | 100.00% | 0.12% |
| NORTHERN TRUST CORP | 02/13/2024 | 14.12 K | $2.56 K | 0.00% | 0.11% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2024 | 13.66 K | $2.47 K | 1.22% | 0.11% |
| MORGAN STANLEY | 08/16/2024 | 11.37 K | $2.06 K | 3.24% | 0.09% |
| TWO SIGMA SECURITIES, LLC | 02/14/2024 | 11.25 K | $2.04 K | 100.00% | 0.09% |
| FRANKLIN RESOURCES INC | 02/09/2024 | 11.00 K | $1.99 K | 0.00% | 0.09% |
| STATE STREET CORP | 02/14/2024 | 10.94 K | $1.98 K | 0.00% | 0.09% |
| DIVERGENT WEALTH ADVISORS | 02/09/2024 | 10.00 K | $1.81 K | 0.00% | 0.08% |
| JPMORGAN CHASE & CO | 12/26/2024 | 1.90 K | $343 | -0.52% | 0.02% |
| WELLS FARGO & COMPANY/MN | 02/09/2024 | 1.62 K | $293 | 3.52% | 0.01% |
| FIFTH THIRD BANCORP | 01/19/2024 | 291 | $53 | 0.00% | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 03/22/2024 | 142 | $26 | 0.00% | 0.00% |
| TRUVESTMENTS CAPITAL LLC | 02/14/2024 | 95 | $17 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 02/12/2024 | 30 | $5 | 0.00% | 0.00% |
| ALLWORTH FINANCIAL LP | 01/24/2024 | 17 | $4 | 0.00% | 0.00% |
| CITIGROUP INC | 02/09/2024 | 10 | $2 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/14/2024 | 6 | $1 | 0.00% | 0.00% |
| UBS GROUP AG | 02/09/2024 | 5 | $1 | -94.12% | 0.00% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/16/2024 | 0 | $0 | -100.00% | 0.00% |
| EARNEST PARTNERS LLC | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Aptevo Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 1 institutional investors and hedge funds held shares of Aptevo Therapeutics Inc.. The most heavily invested institutionals were:
QS Investors, LLC: 15,650
15.37% of Aptevo Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 15.65 K shares in the last 24 months. This purchase volume represents approximately $47.42 K in transactions.